[HTML][HTML] Recent preclinical and clinical progress in liposomal doxorubicin

K Aloss, P Hamar - Pharmaceutics, 2023 - mdpi.com
Doxorubicin (DOX) is a potent anti-cancer agent that has garnered great interest in research
due to its high efficacy despite dose-limiting toxicities. Several strategies have been …

Redox-sensitive nanoscale drug delivery systems for cancer treatment

E Mirhadi, M Mashreghi, MF Maleki… - International journal of …, 2020 - Elsevier
Pharmaceutical nanotechnology introduces novel strategies in designing smart nanoscale
drug delivery systems (NDDSs) capable of responding to specific conditions. These smart …

Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: in vitro and in vivo anti-tumor study

M Karimi, F Gheybi, P Zamani, M Mashreghi… - International journal of …, 2020 - Elsevier
Liposomal formulations were made using Solvent-assisted active loading technology
(SALT). Two formulations composed of HSPC: DPPG: Chol: DSPE-mPEG 2000 (PG …

Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma

ME Nik, B Malaekeh-Nikouei, M Amin, M Hatamipour… - Scientific reports, 2019 - nature.com
Galbanic acid (Gba), a sesquiterpene coumarin, with strong antiangiogenic activity could
serve as an excellent anti-cancer agent. However, Gba is a poor water-solube which …

Construction and characterization of a novel Tenofovir-loaded PEGylated niosome conjugated with TAT peptide for evaluation of its cytotoxicity and anti-HIV effects

MS Yadavar-Nikravesh, S Ahmadi, A Milani… - Advanced Powder …, 2021 - Elsevier
In recent years, nanocarriers have become potent drug delivery system candidates,
especially in anti-HIV therapies. Meanwhile, using cell-penetrating peptides such as TAT for …

Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide

M Mashreghi, M Faal Maleki, M Karimi… - Journal of drug …, 2021 - Taylor & Francis
The aim of this study was to surface-functionalize PEGylated liposomal doxorubicin (PLD)
using anti-p32 CGKRK peptide to evaluate its anti-angiogenic and anti-tumour activities …

TAT-modified self-assembled cationic peptide nanoparticles as an efficient antibacterial agent

B He, S Ma, G Peng, D He - Nanomedicine: Nanotechnology, Biology and …, 2018 - Elsevier
The increasing emergence of drug resistant pathogenic bacteria poses a great challenge to
clinical therapy and a threat to public health. Cationic peptides have received great attention …

[HTML][HTML] Niosome-loaded antifungal drugs as an effective nanocarrier system: A mini review

M Osanloo, S Assadpour, A Mehravaran… - Current medical …, 2018 - ncbi.nlm.nih.gov
Skin is an important organ of the body due to offering an accessible and convenient site for
drug administration. One of the disadvantages of transdermal drug delivery is the low …

Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting

MF Maleki, A Jafari, E Mirhadi, A Askarizadeh… - International journal of …, 2019 - Elsevier
There are various drug delivery systems (DDSs) among which nanoliposomal formulations
are among the most prominent. Despite the superiority of nanoliposomal DDSs compared to …

Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers

S Nikoofal-Sahlabadi, MM Riahi, K Sadri… - European Journal of …, 2018 - Elsevier
Abstract CpG oligodeoxynucleotides (CpG-ODN), a common immune stimulator and vaccine
adjuvant, was reported to switch Tumor Associated Macrophages (TAMs) from M2 to M1 …